These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 1838472)
21. Propionibacterium acnes biotypes and susceptibility to minocycline and Keigai-rengyo-to. Higaki S; Nakamura M; Morohashi M; Yamagishi T Int J Dermatol; 2004 Feb; 43(2):103-7. PubMed ID: 15125499 [TBL] [Abstract][Full Text] [Related]
22. Comparative activity of the topical quinolone OPC-7251 against bacteria associated with acne vulgaris. Vogt K; Hermann J; Blume U; Gollnick H; Hahn H; Haustein UF; Orfanos CE Eur J Clin Microbiol Infect Dis; 1992 Oct; 11(10):943-5. PubMed ID: 1486893 [TBL] [Abstract][Full Text] [Related]
23. Chemotactic efficiency of various chemoattractants for polymorphonuclear leukocytes in inflammatory acne vulgaris. Knop J; Bossecker T; Kövary PM Arch Dermatol Res; 1982; 274(3-4):267-75. PubMed ID: 6219635 [TBL] [Abstract][Full Text] [Related]
24. Complement activation in acne vulgaris: in vitro studies with Propionibacterium acnes and Propionibacterium granulosum. Webster GF; Leyden JJ; Norman ME; Nilsson UR Infect Immun; 1978 Nov; 22(2):523-9. PubMed ID: 153333 [TBL] [Abstract][Full Text] [Related]
25. Propionibacterium acnes resistance to antibiotics in acne patients. Leyden JJ; McGinley KJ; Cavalieri S; Webster GF; Mills OH; Kligman AM J Am Acad Dermatol; 1983 Jan; 8(1):41-5. PubMed ID: 6219134 [TBL] [Abstract][Full Text] [Related]
27. [The resistance of Propionibacterium acnes and Staphylococcus epidermidis to cyclines. The Research and Study Group on Acne]. Noyon V; Legallou F; Richet H; Dreno B Ann Dermatol Venereol; 1998 Dec; 125(12):885-7. PubMed ID: 9922860 [TBL] [Abstract][Full Text] [Related]
28. The feasibility of replacing antibiotics by quaternary ammonium compounds in topical antimicrobial acne therapy. Gloor M; Schorch B; Hoeffler U Arch Dermatol Res; 1979 Jun; 265(2):207-12. PubMed ID: 157107 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of oral antibiotics on acne vulgaris and their effects on quality of life: a multicenter randomized controlled trial using minocycline, roxithromycin and faropenem. Hayashi N; Kawashima M J Dermatol; 2011 Feb; 38(2):111-9. PubMed ID: 21269305 [TBL] [Abstract][Full Text] [Related]
30. Characterization of serum-independent polymorphonuclear leukocyte chemotactic factors produced by Propionibacterium acnes. Webster GF; Leyden JJ Inflammation; 1980 Sep; 4(3):261-9. PubMed ID: 7429606 [TBL] [Abstract][Full Text] [Related]
31. Tetracycline-resistant propionibacteria from acne patients are cross-resistant to doxycycline, but sensitive to minocycline. Eady EA; Jones CE; Gardner KJ; Taylor JP; Cove JH; Cunliffe WJ Br J Dermatol; 1993 May; 128(5):556-60. PubMed ID: 8504049 [TBL] [Abstract][Full Text] [Related]
32. The antibiotic susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne. Nishijima S; Akamatsu H; Akamatsu M; Kurokawa I; Asada Y J Dermatol; 1994 Mar; 21(3):166-71. PubMed ID: 8014270 [TBL] [Abstract][Full Text] [Related]
33. Antimicrobial Activity of Pomegranate and Green Tea Extract on Propionibacterium Acnes, Propionibacterium Granulosum, Staphylococcus Aureus and Staphylococcus Epidermidis. Li Z; Summanen PH; Downes J; Corbett K; Komoriya T; Henning SM; Kim J; Finegold SM J Drugs Dermatol; 2015 Jun; 14(6):574-8. PubMed ID: 26091382 [TBL] [Abstract][Full Text] [Related]
34. In-vitro investigation of anti-acne properties of Mangifera indica L. kernel extract and its mechanism of action against Propionibacterium acnes. Poomanee W; Chaiyana W; Mueller M; Viernstein H; Khunkitti W; Leelapornpisid P Anaerobe; 2018 Aug; 52():64-74. PubMed ID: 29906773 [TBL] [Abstract][Full Text] [Related]
35. Effect of cis-urocanic acid on bovine neutrophil generation of reactive oxygen species. Rinaldi M; Moroni P; Leino L; Laihia J; Paape MJ; Bannerman DD J Dairy Sci; 2006 Nov; 89(11):4188-201. PubMed ID: 17033005 [TBL] [Abstract][Full Text] [Related]
36. Inhibitory effect of azelaic acid on neutrophil functions: a possible cause for its efficacy in treating pathogenetically unrelated diseases. Akamatsu H; Komura J; Asada Y; Miyachi Y; Niwa Y Arch Dermatol Res; 1991; 283(3):162-6. PubMed ID: 1867478 [TBL] [Abstract][Full Text] [Related]